Biotechnology Stocks I Performance Guide: Cartesian Therapeutics, Inc. (RNAC)
RNAC has no dividends.
Table and Chart of RNAC Performance
See what a $1,000 investment in RNAC is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RNAC Returns | |
|---|---|
| Start Date | Jul-29-2016 |
| Start Price | $329.72 |
| End Date | May-17-2024 |
| End Price | $26.43 |
| # Prices | 95 |
| Min Date | Mar-28-2024 |
| Min Price | $19.50 |
| Max Date | Oct-31-2017 |
| Max Price | $636.60 |
| Total Return | -91.98% |
| Annualized Return | -27.30% |
| Current Value of $1,000 Purchase | $80 |
| Number Returns | 4,465 |
| Average Return | -43.60% |
| Number Profitable Returns | 807 |
| Percent Profitable Returns | 18.07% |
| Number Unprofitable Returns | 3,658 |
| Percent Unprofitable Returns | 81.93% |
| Profitable to Unprofitable Returns Ratio | 0.22 |
| RNAC Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $470,351,000 |
| Beta | 0.832 | Price to Sales | 13.26 |
| Earnings per Share | $-0.2900 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 31.26 |
| PRICE DATA | |
| 52 Week High | $42.6 |
| 52 Week Low | $11.66 |
| Analyst Target Price | $51 |
| 50-Day Moving Average | $19.95 |
| 200-Day Moving Average | $26.3 |
| FINANCIAL DATA | |
| Revenue per Share | $4.938 |
| Revenue | $25,906,000 |
| Profit Margin | 0% |
| Return on Equity | -49.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RNAC Compare Returns with S&P 500
RNAC Trendline Chart
RNAC Moving Average Chart
RNAC Stock Return Map - See Patterns of Gains and Losses
RNAC Stock Returns/Purchase Dates